Ustekinumab efficacy and safety in Crohn's disease patients refractory to conventional and anti-TNF therapy: a multicenter retrospective experience. - Archive ouverte HAL Accéder directement au contenu
Communication Dans Un Congrès Journal of Crohn's and Colitis Année : 2015

Ustekinumab efficacy and safety in Crohn's disease patients refractory to conventional and anti-TNF therapy: a multicenter retrospective experience.

(1) , (2) , (3) , (4) , (5) , (6) , (7) , (8) , (9) , (10) , (11) , (12) , (13) , (14) , (15) , (16) , (17) , (1)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
Matthieu Allez
Bernard Duclos
  • Fonction : Auteur

Dates et versions

hal-03553426 , version 1 (02-02-2022)

Licence

Paternité - Pas d'utilisation commerciale - CC BY 4.0

Identifiants

Citer

Pauline Wils, Yoram Bouhnik, Bernard Flourie, Hédia Brixi, Jacques Cosnes, et al.. Ustekinumab efficacy and safety in Crohn's disease patients refractory to conventional and anti-TNF therapy: a multicenter retrospective experience.. 10. Congress of ECCO, European Crohn's and Colitis Organisation, Feb 2015, Barcelone, Spain. pp.S37-S39, ⟨10.1093/ecco-jcc/jju027.057⟩. ⟨hal-03553426⟩
33 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More